Media coverage about HCP (NYSE:HCP) has been trending positive on Saturday, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. HCP earned a news sentiment score of 0.26 on Accern’s scale. Accern also gave news headlines about the real estate investment trust an impact score of 45.2570700870314 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the headlines that may have impacted Accern’s rankings:

Shares of HCP (NYSE:HCP) traded up $0.07 on Friday, reaching $25.67. 2,935,933 shares of the company traded hands, compared to its average volume of 3,820,000. The stock has a market cap of $12,070.00, a price-to-earnings ratio of 45.84, a P/E/G ratio of 2.72 and a beta of 0.33. HCP has a 12-month low of $25.08 and a 12-month high of $33.67. The company has a debt-to-equity ratio of 1.17, a quick ratio of 0.61 and a current ratio of 0.61.

HCP (NYSE:HCP) last issued its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. The firm had revenue of $454.00 million for the quarter, compared to analyst estimates of $440.60 million. HCP had a net margin of 27.31% and a return on equity of 8.85%. HCP’s revenue was down 14.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.72 EPS. research analysts anticipate that HCP will post 1.94 earnings per share for the current year.

Several brokerages have issued reports on HCP. Stifel Nicolaus reaffirmed a “hold” rating and set a $30.00 target price on shares of HCP in a research note on Wednesday, October 4th. Morgan Stanley reaffirmed an “equal weight” rating and set a $29.00 target price on shares of HCP in a research note on Thursday, December 14th. J P Morgan Chase & Co raised shares of HCP from a “neutral” rating to an “overweight” rating and set a $29.00 target price on the stock in a research note on Friday, December 15th. BMO Capital Markets reaffirmed a “hold” rating and set a $28.00 target price on shares of HCP in a research note on Wednesday, October 18th. Finally, KeyCorp reaffirmed a “hold” rating on shares of HCP in a research note on Tuesday, October 17th. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $30.78.

ILLEGAL ACTIVITY NOTICE: This report was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Insider Buying and Selling by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with's FREE daily email newsletter.